TickerFactsScreenerDevelopers

Twist Bioscience Corp (TWST) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$51.30M2018: -$66.16M2019: -$87.94M2020: -$142.25M2021: -$112.24M2022: -$124.39M2023: -$142.47M2024: -$64.09M2025: -$47.63M-$47.63M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$47.63M+25.7%
2024-$64.09M+55.0%
2023-$142.47M-14.5%
2022-$124.39M-10.8%
2021-$112.24M+21.1%
2020-$142.25M-61.8%
2019-$87.94M-32.9%
2018-$66.16M-29.0%
2017-$51.30M—